Nir Sassi
Chief Financial Officer at Indaptus Therapeutics, Inc. (INDP)
Nir Sassi has filed 4 insider reports with the SEC since January 2023, as chief Financial Officer at Indaptus Therapeutics, Inc. (INDP). The latest filing, on December 29, 2025, reports grant or award at Indaptus Therapeutics, Inc. (INDP).
- Filings
- 4
- Companies
- 1
- Bought on market
- None
- Sold on market
- None
Companies where Nir Sassi is an insider
| Company | Role | Shares held | Bought | Sold | Avg buy | Price now | Last filing |
|---|---|---|---|---|---|---|---|
| INDP Indaptus Therapeutics, Inc. | Chief Financial Officer | 26,758 | $3.13 | Dec 29, 2025 |
Shares held: common shares owned directly after the latest filing that states it. Avg buy: open-market purchase dollars divided by shares bought, every filing on record.
Every filing
- Dec 22, 2025INDPChief Financial Officer Sassi Nir was granted 26,758 sharesForm 4Grant or award
- Oct 9, 2024INDPSEC Form 4 filed by Chief Financial Officer Sassi NirForm 4Grant or award
- Jan 22, 2024INDPSEC Form 4 filed by Sassi NirForm 4Grant or award
- Jan 18, 2023INDPSEC Form 4 filed by Sassi NirForm 4Grant or award
Compare Nir Sassi with
- Nir Sassi vs Junyi Dai1 shared
- Nir Sassi vs David E. Lazar1 shared
- Nir Sassi vs Jerome D Jabbour1 shared
- Nir Sassi vs Matthew Charles McMurdo1 shared
- Nir Sassi vs Jeffrey A Meckler1 shared
- Nir Sassi vs Avraham Ben-Tzvi1 shared
Other insiders at the same companies
- Qinglai LuINDP
- Yun YaoINDP
- SINO LION VENTURES LtdINDP
- Junyi DaiINDP
- David E. LazarINDP
- Jerome D JabbourINDP
- Matthew Charles McMurdoINDP
- Jeffrey A MecklerINDP
- Avraham Ben-TzviINDP
- David NatanINDP
- Walt Addison LinscottINDP
- Michael James NewmanINDP
- Robert MartellINDP
- Hila KarahINDP
- Roger PomerantzINDP
- William B HayesINDP
Questions about Nir Sassi
- What is Nir Sassi's role at Indaptus Therapeutics, Inc.?
- Nir Sassi reports to the SEC as chief Financial Officer at Indaptus Therapeutics, Inc. (INDP), according to the latest filing on December 29, 2025.
- How many shares does Nir Sassi own?
- After the latest filing that states it, Nir Sassi directly owned 26,758 shares of Indaptus Therapeutics, Inc. (INDP). Shares held through trusts, funds or family members are reported separately and are not counted here.
- Has Nir Sassi bought or sold stock recently?
- No open-market purchases or sales by Nir Sassi are on file. The filings report grant or award.
- How do I get alerts when Nir Sassi files?
- Follow Nir Sassi on Quantisnow and you get an email, and a phone notification on Plus, within minutes of each new Form 4 or Form 5, and of each Form 144 notice of a planned sale.
From SEC Forms 3, 4, 5 and 144 filed by Nir Sassi (SEC CIK 0001760673). Totals count each trade once, skipping amendments whose original is on file, from Jan 20, 2023 on. View on SEC EDGAR